These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6347)

  • 21. Tolerance to skin allografts by immunosuppressive "pulse" of methylhydrazine derivatives and antilymphocyte serum.
    Floersheim GL; Brune K
    Transplant Proc; 1971 Mar; 3(1):688-92. PubMed ID: 4398510
    [No Abstract]   [Full Text] [Related]  

  • 22. Immunological enhancement of muscle allografts induced by serum from tolerant rats.
    Gutmann E; Hasek M; Chutná J
    Folia Biol (Praha); 1978; 24(1):25-31. PubMed ID: 344077
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Skin allograft survival following intrathymic injection of donor bone marrow.
    Cober SR; Randolph MA; Lee WP
    J Surg Res; 1999 Aug; 85(2):204-8. PubMed ID: 10423320
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunosuppressive and graft-rejecting anti--bodies in heterologous anti-lymphocytic serum.
    Cinader B; Jeejeebhoy HF; Koh SW; Rabbat AG
    J Exp Med; 1971 Jan; 133(1):81-99. PubMed ID: 4924199
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of tolerance to skin allografts by intrathymic injection of donor splenocytes. Effect of donor-recipient strain combination and supplemental rapamycin.
    Dono K; Maki T; Wood ML; Monaco AP
    Transplantation; 1995 Dec; 60(11):1268-73. PubMed ID: 8525521
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tissue-specific differences in the establishment of tolerance. Tolerogenic effects of lung allografts in rats.
    Vriens PW; Nisco SJ; Hoyt EG; Lyu SC; Pierre P; Reitz BA; Clayberger C
    Transplantation; 1994 Jun; 57(12):1795-8. PubMed ID: 8016886
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bone marrow grafts and histocompatibility.
    Amiel JL; Schwarzenberg L; Mathé G
    Transplant Proc; 1971 Jun; 3(2):1072-7. PubMed ID: 4400010
    [No Abstract]   [Full Text] [Related]  

  • 28. Antilymphocytic antibodies and marrow transplantation. V. Suppression of secondary disease by host-versus-theta-graft reaction.
    Thierfelder S; Rodt H
    Transplantation; 1977 Jan; 23(1):87-92. PubMed ID: 319574
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The influence of histocompatibility and antithymocyte serum on the ability of alloantigenic pretreatment to prolong the survival of mouse skin grafts.
    Cohen N; Latorre JA
    Folia Biol (Praha); 1975; 21(1):33-42. PubMed ID: 1091518
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improved survival of heart transplants. Graft and/or donor pretreatment with antilymphoblast globulin, cyclophosphamide, or methylprednisolone.
    Toledo-Pereyra LH; Condie RM
    J Thorac Cardiovasc Surg; 1978 Apr; 75(4):536-41. PubMed ID: 347179
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immune capacity of mice tolerating a weakly incompatible skin allograft. I. Tolerance induction by neonatal skin graft in adult recipients or by neonatal inoculation of adult cells.
    Viklický V; Poláckovä M; Wabik B
    Folia Biol (Praha); 1975; 21(4):209-18. PubMed ID: 1102343
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prevention of the graft vs host reaction in rats by means of allogeneic antilymphocyte serum following bone marrow transplantation].
    Jeannet M; Vaucher A; Gervasoni C
    Schweiz Med Wochenschr; 1972 Nov; 102(44):1598-600. PubMed ID: 4405059
    [No Abstract]   [Full Text] [Related]  

  • 33. Prolonged survival in syngeneic females of skin grafts from males pretreated with an antiandrogenic steroid.
    Vojtiskova M; Polaácková M
    Folia Biol (Praha); 1973 Sep; 19(5):381-4. PubMed ID: 4129641
    [No Abstract]   [Full Text] [Related]  

  • 34. Mode of action of antilymphocyte sra (ALS).
    Harris NS; Merino GE; Najarian JS
    Transplant Proc; 1971 Mar; 3(1):797-9. PubMed ID: 4398511
    [No Abstract]   [Full Text] [Related]  

  • 35. Bone marrow transplantation.
    Santos GW
    Adv Intern Med; 1979; 24():157-82. PubMed ID: 34319
    [No Abstract]   [Full Text] [Related]  

  • 36. Immunocompetence in regional graft-versus-host reaction of blood cells from skin allografted or ALS treated rats.
    Hasková V; Gansová E; Hajná I
    Folia Biol (Praha); 1973; 19(4):261-6. PubMed ID: 4148073
    [No Abstract]   [Full Text] [Related]  

  • 37. Indirect evidence of two adverse components of the humoral response to skin allografts as revealed in ALS-suppressed mice.
    Nouza K; Hilgert I; Nĕmec M; Kristofová H
    Folia Biol (Praha); 1972; 18(4):264-9. PubMed ID: 4559929
    [No Abstract]   [Full Text] [Related]  

  • 38. Cytology and histology of haemopoietic cell transplantation under the influence of ALS in mice. II. The effect of marrow from donors pretreated with antilymphocyte serum (ALS) on the recipient.
    Thierfelder S; Rodriguez-Paradisi E; Mempel W; Beil E
    Clin Exp Immunol; 1971 Jan; 8(1):121-9. PubMed ID: 4395674
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The feasibility of altering the immunogenicity of grafts.
    Billingham RE
    J Invest Dermatol; 1976 Jul; 67(1):149-59. PubMed ID: 819591
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunosuppression in rabbits: skin and kidney allografts.
    Green CJ
    Lab Anim; 1975 Jul; 9(3):223-32. PubMed ID: 1099335
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.